Peripheral blood circulating multiple myeloma cells (CMMCs) correlate with disease burden and can be used to characterize high-risk cytogenetics in newly diagnosed and smoldering myeloma

Category Primary study
JournalCancer Research
Year 2016
This article has no abstract
Epistemonikos ID: 44bbc9ce794ae65a1747c661c19cd0ae3f92693f
First added on: Feb 08, 2025